India  

Cadila Healthcare

Indian multinational pharmaceutical company

Cadila Healthcare    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Cadila Healthcare: Indian multinational pharmaceutical company
Cadila Healthcare Limited is an Indian multinational pharmaceutical company headquartered in Ahmedabad, Gujarat, India primarily engaged in the manufacture of generic drugs. It ranked 100th in the Fortune India 500 list in 2020.

0
shares
ShareTweetSavePostSend
 
DNA based Covid-19 vaccines Zycov-D to be introduced in 7 Indian states | Oneindia News [Video]

DNA based Covid-19 vaccines Zycov-D to be introduced in 7 Indian states | Oneindia News

World’s first needleless Covid-19 vaccine, ZyCov-D, manufactured by Zydus Cadila, will be first introduced in 7 states in India. These seven states include West Bengal, Maharashtra, meanwhile, the..

Credit: Oneindia     Duration: 02:00Published

You Might Like


Zydus Cadila's COVID-19 vaccine ZyCoV-D to be launched in THESE seven states initially

Zydus Cadila's COVID-19 vaccine ZyCoV-D will be introduced in seven Indian states in the first rollout, as per the health ministry.
DNA - Published

Zydus Cadila gets USFDA nod to market generic cancer drug in US


IndiaTimes - Published

Zydus Cadila's Covid vaccine to be administered only to adults as of now: Sources

Zydus Cadila's COVID-19 vaccine ZyCov-D, which has been cleared by India's drug regulator for those aged 12 years and above, will only be administered to adults as of now under the government's..
IndiaTimes - Published

Zydus Cadila to supply 1 crore doses of its 'needle-free' COVID-19 vaccine to govt at this price

The ZyCoV-D vaccine will be given through a needle-free applicator instead of a syringe.
DNA - Published

India to buy 10 million doses of Zydus Cadila's Covid-19 vaccine at about $4 each


IndiaTimes - Published

Zydus Cadila agrees to reduce its Covid vaccine price to Rs 265 a dose, final decision soon: Sources


IndiaTimes - Published

Procurement price of Zydus vax fixed, roll out soon: Govt


IndiaTimes - Published

Kids’ vaccine ZyCoV-D to be given to private hospitals too

The needle-free ZyCoV-D vaccine, manufactured by Zydus Cadila, has received emergency use authorisation for being administered to children between 12 and 17 years of age in India. The three-dose..
IndiaTimes - Published

Zydus Cadila proposes Rs 1900 for three-dose Covid vaccine; government negotiating to bring it down


IndiaTimes - Published

'Centre hopeful of positive outcome from final talks with Zydus Cadila for Covid vaccine for kids'

The Centre is hopeful of a positive outcome from the final round of discussions currently underway with Zydus Cadila for its Covid-19 vaccine for children, Karnataka Health Minister K Sudhakar said on..
IndiaTimes - Published

Covid: Zydus vaccine to be introduced in inoculation drive soon


IndiaTimes - Published

Centre likely to roll out 1 crore doses of Zydus Cadila's COVID-19 vaccine ZyCoVD by October - All you need to know

On PM Narendra Modi's 71st birthday, India set a new record for single-day vaccinations and administered over 2 crore COVID-19 vaccine doses.
DNA - Published

Zydus Cadila to seek approval for two-dose regimen of its approved three-dose Covid-19 vaccine in India


IndiaTimes - Published

Zydus Cadila's Covid-19 vaccine can be available from first week of October

The Union government is expecting Zydus Cadila's needle-free Covid-19 vaccine ZyCoV-D to be available from the first week of October. Further, a decision on whether all children or only those with..
IndiaTimes - Published

ZyCoV-D COVID vaccine likely to be available in market by mid to end September: MD Sharvil Patel

The ZyCoV-D COVID-19 vaccine, which received emergency use authorisation from India's drug regulator on Friday, will be available in the market by mid to end September, Zydus Group Managing Director..
DNA - Published

A momentous feat: PM Narendra Modi after Zydus Cadila's Covid vaccine gets emergency use authorisation

The department of biotechnology on Friday said indigenously developed Zydus Cadila Covid-19 vaccine ZyCoV-D has received approval for emergency use authorisation from the Drug Controller General of..
IndiaTimes - Published

Government approves first Covid-19 vaccine for children above 12 years

The company has indicated an initial visibility of supplying around 5 crore doses by December, a senior official said. While the government is yet to sign a final agreement with Cadila, supplies to the..
IndiaTimes - Published

Government panel recommends emergency use authorisation to Zydus Cadila's 3-dose Covid vaccine

The subject expert committee (SEC) on Covid-19 of the Central Drugs Standard Control Organisation (CDSCO) deliberated on the application given by Zydus Cadila on Thursday and recommended granting..
IndiaTimes - Published

Covid vaccination for kids may start only by March ’22

Zydus Cadila's Covid-19 vaccine, ZyCoV-D, is expected to get an emergency use authorisation for the 12-18 cohort by end of August, whereas Bharat Biotech’s Covaxin – the world’s only vaccine..
IndiaTimes - Published

AIIMS to begin second dose trial of Bharat Biotech's Covaxin on children between 2-6 years

Not just Bharat Biotech's Covaxin but Zydus Cadila's vaccine for children is also currently under trial in India
DNA - Published

DCGI likely to approve Zydus Cadila's vaccine for children above 12 years

Zydus Cadila's COVID-19 vaccine, ZyCov-D, is a three-dose, intradermal vaccine which is applied using the PharmaJet needle-free system
DNA - Published

Zydus’ vaccine for kids above 12 to come up for approval this week

The vaccine has been tested on adults as well as children above 12 and if the regulatory committee is satisfied with the submitted data and documents, the vaccine will be approved for emergency use..
IndiaTimes - Published

Vaccination of children with Zydus vaccine will begin by September: Expert Panel Chief

Vaccination of children with Zydus vaccine will begin by September. Focus on vaccinating children is due to threat perception for them in third wave.
DNA - Published

Zydus seeks nod for world’s first plasmid DNA Covid vax

Homegrown healthcare and pharmaceutical major Zydus Cadila has applied for emergency use authorisation (EUA) to the office of the Drug Controller General of India for ZyCoV-D, its plasmid DNA vaccine..
IndiaTimes - Published

Zydus Cadila seeks approval for its 3-dose Covid vaccine

Indian drugmaker Zydus Cadila said on Thursday it has applied for emergency use approval of its three-dose Covid-19 vaccine that showed efficacy of 66.6% in an interim study and could become the second..
IndiaTimes - Published

Vaccination for Children: Zydus Cadila vaccine for 12-18 age group to be available soon, Centre informs Supreme Court

Centre tells SC that pharmaceutical company Zydus Cadila has concluded the clinical trials of its vaccine for the age group of 12 to 18.
DNA - Published

Zydus Cadila likely to seek emergency authorisation for ZyCoV-D Covid-19 vaccine in 7-8 days

Pharmaceutical major Zydus Cadila has told the Centre that it could apply for emergency use authorisation (EUA) for ZyCoV-D vaccine in the next seven-eight days.
IndiaTimes - Published

Vaccine for 12+: Zydus may seek licence in 2 weeks


IndiaTimes - Published

Zydus: 80% of enrolment over for vaccine trial in 12-18 age group


IndiaTimes - Published

Zydus Cadila seeks human trial approval for Covid-19 antibody cocktail

India's Zydus Cadila has sought regulatory approval for clinical trials of its antibody cocktail to treat mild Covid-19. The treatment candidate, ZRC-3308, was earlier shown to reduce lung damage..
IndiaTimes - Published

Zydus Cadila's Virafin granted restricted emergency use approval for treating Covid patients: DBT


IndiaTimes - Published Also reported by •DNA

Zydus Cadila Healthcare starts producing Covid-19 vaccine


IndiaTimes - Published

Zydus Cadila gets DCGI nod for hepatitis drug for Covid-19 treatment

Drug firm Zydus Cadila on Friday said it has received restricted emergency use approval from the Indian drug regulator for the use of Pegylated Interferon alpha-2b (PegIFN) in treating moderate..
IndiaTimes - Published

Zydus vaccine to cover children too


IndiaTimes - Published

Companies set to double Remdesivir output

Even as the Centre announced a slew of measures to improve access of Covid-19 therapy, Remdesivir, major players including Zydus Cadila, Cipla, Mylan and Dr Reddy’s are ramping up production, which..
IndiaTimes - Published

Zydus Cadila gets DCGI nod to initiate Phase-3 clinical trials for Covid-19 vaccine


IndiaTimes - Published

Zydus Cadila gets permission from DCGI for phase-1 clinical trial of novel molecule ZYIL1

Drug firm Zydus Cadila on Monday said it has received permission from Drugs Controller General of India (DCGI) to initiate phase-1 clinical trial of its novel molecule ZYIL1, indicated for use as an..
IndiaTimes - Published

Covid-19: Zydus Cadila gets DGCI nod for phase 3 clinical trials with biological therapy


IndiaTimes - Published

Gujarat: PM Modi reviews vaccine development at Zydus Cadila facility

Prime Minister Narendra Modi on Saturday began his three-city visit to review coronavirus vaccine development work by going to pharma major Zydus Cadila's manufacturing facility near Ahmedabad. After..
IndiaTimes - Published

PM Modi reaches Ahmedabad to review coronavirus vaccine development

Prime Minister Narendra Modi landed here on Saturday as part of his three-city visit to ireview coronavirus vaccine development work at facilities there, an official said. From the airport, Modi..
IndiaTimes - Published

PM to visit Zydus' Covid-19 vaccine development centre in Gujarat


IndiaTimes - Published

PM to visit vaccine centres in 3 cities

While in Hyderabad, the PM will visit vaccine maker Bharat Biotech’s facilities, where work on the development of India’s first indigenous Covid-19 vaccine, Covaxin, is under way, he will drop in..
IndiaTimes - Published

India to get COVID-19 vaccine by mid-2021, says Biocon's Kiran Mazumdar-Shaw

Besides, Bharat Biotech, Zydus Cadila Ltd is also in Phase 2 of human clinical trials of a COVID-19 vaccine.
DNA - Published

For high-risk groups, government plans to fast-track vaccine

India has three vaccines in advanced stages of trial. The vaccine candidate developed by Oxford University and AstraZeneca and proposed in India by Serum Institute is ahead and is set to enter phase 3...
IndiaTimes - Published

Covid-19 vaccine: Govt panel meets representatives of leading domestic manufacturers

The national expert group on vaccine administration for Covid-19 met representatives of leading domestic manufactures, including Serum Institute of India, Bharat Biotech and Zydus Cadila, on Monday to..
IndiaTimes - Published

National Expert Group discusses vaccine development with domestic manufactures

National Expert Group on Vaccine Administration on Monday met leading domestic vaccine manufactures- Serum Institute of India, Pune; Bharat Biotech, Hyderabad; Zydus Cadila, Ahmedabad; Gennova..
DNA - Published

Zydus' 'budget' injection costs 2,800/shot

Ahmedabad-based Zydus Cadila announced the launch of its anti-viral Remdesivir drug at Rs 2,800 per injection, making it the "most economical" brand in the country.
IndiaTimes - Published

COVID-19: Drug firm Zydus Cadila launches India's cheapest remdesivir version at Rs 2,800

Yet again, India witnessed the highest-ever single-day spike of 66,999 new COVID-19 cases the last 24 hours.
DNA - Published

Zydus Cadila gets USFDA nod for drug trials to treat chemotherapy-induced anemia

In a regulatory filing, Zydus Cadila said it has received approval from the US Food and Drug Administration (USFDA) to initiate clinical trials of Desidustat in CIA. Zydus Cadila Chairman Pankaj R..
IndiaTimes - Published

Seven Indian pharma players race to develop Covid-19 vaccine

At least seven Indian pharma companies are working to develop a vaccine against coronavirus as they join global efforts to find a preventive to check the spread of the deadly virus that has already..
IndiaTimes - Published


 Page 1  〉